Denmark· DK-28101596894
Serevent
A salmeterol product containing salmeterolxinafoat, registered in Denmark by GlaxoSmithKline Pharma A/S. The same ATC class is registered in 19 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Salmeterol is registered in 19 of 19 countries.
Countries holding a registration under ATC R03AC12 (salmeterol), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 11 of them publish a price we can compare per daily dose
Salmeterol · ATC R03AC12
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- SALMETEROLXINAFOAT
- Manufacturer
- GlaxoSmithKline Pharma A/S
- Country
- Denmark (DK)
- ATC code
- R03AC12
- ATC class
- Salmeterol
- Defined daily dose
- 0.1 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101596894
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
719 interactions on record for salmeterol.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Salmeterol · interactions on record
719 records
- 49 severe
- 397 moderate
- 24 minor
- 248 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- PindololC07AA03severe
- PropranololC07AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03AC12
Salmeterol, as other registers publish it.
- PolandAsmeticPolfarmex S.A.
- SpainBEGLAN 25 microgramos/inhalación, suspensión para inhalación en envase a presiónGlaxosmithkline S.A.
- SpainBEGLAN ACCUHALER 50 microgramos/inhalación, polvo para inhalaciónGlaxosmithkline S.A.
- SpainBETAMICAN 25 microgramos/inhalación SUSPENSION PARA INHALACION EN ENVASE A PRESIONGlaxosmithkline S.A.
- SpainBETAMICAN ACCUHALER 50 microgramos/inhalación POLVO PARA INHALACIONGlaxosmithkline S.A.
- SpainINASPIR 25 microgramos/inhalacion SUSPENSION PARA INHALACION EN ENVASE A PRESIONGlaxosmithkline S.A.
- SpainINASPIR ACCUHALER 50 microgramos/inhalacion, POLVO PARA INHALACIONGlaxosmithkline S.A.
- United KingdomNeovent 25micrograms/dose inhaler CFC freeTeva UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c7619414-6355-4a9e-8c11-828132b25406 GET /v1/drugs/c7619414-6355-4a9e-8c11-828132b25406?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "inhalationspulver",
"source": "dkma",
"strength": "50 mikrog. i diskos",
"auth_role": "DKMA",
"dk_drugid": "28101596894",
"substance": "SALMETEROLXINAFOAT",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "34822"
}See everything about salmeterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.